Skip to main content
Erschienen in:

07.01.2021 | Clinical Investigation

Viscotrabeculotomy versus trabeculectomy in the surgical treatment of open angle glaucoma: a single center, randomised controlled trial

verfasst von: Ahmed S. Elwehidy, Tharwat H. Mokbel, Nader H. L. Bayoumi, Amani E. Badawi, Sherein M. Hagras

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of the study was to compare the effect of viscotrabeculotomy and the effect of trabeculectomy on the intraocular pressure (IOP) in cases of open angle glaucoma (OAG).

Study design

Prospective comparative study.

Patients and methods

The study was conducted on 148 eyes of 148 patients (87 men) presenting with and operated upon for OAG at Mansoura Ophthalmic center of Mansoura University in Mansoura, Egypt from 2012 to 2016. Patients were randomized into viscotrabeculotomy and trabeculectomy groups. Postoperative follow up visits were scheduled at weeks 1 and 2 then months 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24. Complications were noted and managed according to needs. The primary outcome measure was IOP.

Results

The study was conducted on 148 eyes (74 right) of 148 patients (87 men). The mean ± SD (range, median) age of the study patients was 50.1 ± 11.5 (20–67, 53) and 51.1 ± 10.0 (27–65, 54.5) years respectively. The mean ± SD (range, median) IOP of the study eyes on maximal tolerated IOP lowering therapy was 23.15 ± 2.31 (19–30, 23.0) and 23.64 ± 1.87 (20–28, 23.0) mmHg respectively and at the end of the 24 months of follow up was 14.91 ± 2.4 (12–23, 14) and 16.64 ± 2.8 (14–25, 16) mmHg respectively (p =  < 0.0005). Notable complications included a mild hyphema in the viscotrabeculotomy group and an IOP spike in the trabeculectomy group.

Conclusions

Viscotrabeculotomy and trabeculectomy showed efficacy and safety in OAG patients. The former resulted in better IOP reduction.
Literatur
2.
Zurück zum Zitat Morrison JC, Pollack IP, editors. Glaucoma: science and practice. New York: Thieme; 2003. p. 154–5. Morrison JC, Pollack IP, editors. Glaucoma: science and practice. New York: Thieme; 2003. p. 154–5.
3.
Zurück zum Zitat Chan KKW, Tang F, Tham CCY, Young AL, Cheung CY. Retinal vasculature in glaucoma: a review. BMJ Open Ophthalmol. 2017;1:e000032.CrossRef Chan KKW, Tang F, Tham CCY, Young AL, Cheung CY. Retinal vasculature in glaucoma: a review. BMJ Open Ophthalmol. 2017;1:e000032.CrossRef
4.
Zurück zum Zitat Lee SH, Kim T-W, Lee EJ, Girard MJA, Mari JM, Ritch R. Ocular and clinical characteristics associated with the extent of posterior lamina cribrosa curve in normal tension glaucoma. Sci Rep. 2018;8:961.CrossRef Lee SH, Kim T-W, Lee EJ, Girard MJA, Mari JM, Ritch R. Ocular and clinical characteristics associated with the extent of posterior lamina cribrosa curve in normal tension glaucoma. Sci Rep. 2018;8:961.CrossRef
5.
Zurück zum Zitat Evangelho K, Mogilevskaya M, Losada-Barragan M, Vargas-Sanchez JK. Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature. Int Ophthalmol. 2019;39:259–71.CrossRef Evangelho K, Mogilevskaya M, Losada-Barragan M, Vargas-Sanchez JK. Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature. Int Ophthalmol. 2019;39:259–71.CrossRef
6.
Zurück zum Zitat Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, Early Manifest Glaucoma Trial G. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268–79.CrossRef Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, Early Manifest Glaucoma Trial G. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268–79.CrossRef
7.
Zurück zum Zitat Rajurkar K, Dubey S, Gupta PP, John D, Chauhan L. Compliance to topical anti-glaucoma medications among patients at a tertiary hospital in North India. J Curr Ophthalmol. 2018;30:125–9.CrossRef Rajurkar K, Dubey S, Gupta PP, John D, Chauhan L. Compliance to topical anti-glaucoma medications among patients at a tertiary hospital in North India. J Curr Ophthalmol. 2018;30:125–9.CrossRef
8.
Zurück zum Zitat Tanna AP, Johnson M. Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension. Ophthalmology. 2018;125:1741–56.CrossRef Tanna AP, Johnson M. Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension. Ophthalmology. 2018;125:1741–56.CrossRef
9.
Zurück zum Zitat Jacob TF, Singh V, Dixit M, Ginsburg-Shmuel T, Fonseca B, Pintor J, et al. A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist. Purinergic Signal. 2018;14:271–84.CrossRef Jacob TF, Singh V, Dixit M, Ginsburg-Shmuel T, Fonseca B, Pintor J, et al. A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist. Purinergic Signal. 2018;14:271–84.CrossRef
10.
Zurück zum Zitat Liang YB, Wu HX, Liao N, Li M, Zhang Q, Wang PJ, et al. Trends of application of topical anti-glaucoma topical drugs in the Eye Hospital of Wenzhou Medical University for ten years. Zhonghua Yan Ke Za Zhi. 2018;54:520–5 ((in Chinese)).PubMed Liang YB, Wu HX, Liao N, Li M, Zhang Q, Wang PJ, et al. Trends of application of topical anti-glaucoma topical drugs in the Eye Hospital of Wenzhou Medical University for ten years. Zhonghua Yan Ke Za Zhi. 2018;54:520–5 ((in Chinese)).PubMed
11.
Zurück zum Zitat Dietlein TS, Moalem Y, Lappas A, Rosentreter A. Glaucoma filtering surgery in the elderly over eighty years old: an analysis of postoperative risks. Klin Monbl Augenheilkd. 2014;231:1224–9 ((in German)).CrossRef Dietlein TS, Moalem Y, Lappas A, Rosentreter A. Glaucoma filtering surgery in the elderly over eighty years old: an analysis of postoperative risks. Klin Monbl Augenheilkd. 2014;231:1224–9 ((in German)).CrossRef
12.
Zurück zum Zitat Leleu I, Penaud B, Blumen-Ohana E, Rodallec T, Adam R, Laplace O, et al. Central 10-degree visual field change following non-penetrating deep sclerectomy in severe and end-stage glaucoma: preliminary results. Graefes Arch Clin Exp Ophthalmol. 2018;256:1489–98.CrossRef Leleu I, Penaud B, Blumen-Ohana E, Rodallec T, Adam R, Laplace O, et al. Central 10-degree visual field change following non-penetrating deep sclerectomy in severe and end-stage glaucoma: preliminary results. Graefes Arch Clin Exp Ophthalmol. 2018;256:1489–98.CrossRef
13.
Zurück zum Zitat Hohberger B, Welge-Lüßen UC, Lämmer R. MIGS: therapeutic success of combined Xen Gel Stent implantation with cataract surgery. Graefes Arch Clin Exp Ophthalmol. 2018;256:621–5.CrossRef Hohberger B, Welge-Lüßen UC, Lämmer R. MIGS: therapeutic success of combined Xen Gel Stent implantation with cataract surgery. Graefes Arch Clin Exp Ophthalmol. 2018;256:621–5.CrossRef
14.
Zurück zum Zitat Arish M, Khallaghi H, Soltani ER. A comparative study of sutureless scleral tunnel trabeculectomy versus conventional trabeculectomy in the management of primary open-angle glaucoma. Int Ophthalmol. 2014;34:1055–9.CrossRef Arish M, Khallaghi H, Soltani ER. A comparative study of sutureless scleral tunnel trabeculectomy versus conventional trabeculectomy in the management of primary open-angle glaucoma. Int Ophthalmol. 2014;34:1055–9.CrossRef
15.
Zurück zum Zitat Kinoshita-Nakano E, Nakanishi H, Ohashi-Ikeda H, Morooka S, Akagi T. Comparative outcomes of trabeculotomy ab externo versus trabecular ablation ab interno for open angle glaucoma. Jpn J Ophthalmol. 2018;62:201–8.CrossRef Kinoshita-Nakano E, Nakanishi H, Ohashi-Ikeda H, Morooka S, Akagi T. Comparative outcomes of trabeculotomy ab externo versus trabecular ablation ab interno for open angle glaucoma. Jpn J Ophthalmol. 2018;62:201–8.CrossRef
16.
Zurück zum Zitat Dang Y-L, Wang X, Dai W-W, Huang P, Loewen NA, Zhang C, et al. Two-year outcomes of ab interno trabeculectomy with the Trabectome for Chinese primary open angle glaucoma: a retrospective multicenter study. Int J Ophthalmol. 2018;11:945–50.PubMedPubMedCentral Dang Y-L, Wang X, Dai W-W, Huang P, Loewen NA, Zhang C, et al. Two-year outcomes of ab interno trabeculectomy with the Trabectome for Chinese primary open angle glaucoma: a retrospective multicenter study. Int J Ophthalmol. 2018;11:945–50.PubMedPubMedCentral
17.
Zurück zum Zitat Otsu Y, Matsuoka M, Koshibu K, Miwa K, Kuro M, Minamino KT, et al. Reduction of intraocular pressure by additional trabeculotomy Ab Externo in eyes with primary open-angle glaucoma. J Glaucoma. 2018;27:914–9.CrossRef Otsu Y, Matsuoka M, Koshibu K, Miwa K, Kuro M, Minamino KT, et al. Reduction of intraocular pressure by additional trabeculotomy Ab Externo in eyes with primary open-angle glaucoma. J Glaucoma. 2018;27:914–9.CrossRef
18.
Zurück zum Zitat ElSheikha OZ, Abdelhakim MA, Elhilali HM, Kassem RR. Is viscotrabeculotomy superior to conventional trabeculotomy in the management of Egyptian infants with congenital glaucoma? Acta Ophthalmol. 2015;93:e366–71.CrossRef ElSheikha OZ, Abdelhakim MA, Elhilali HM, Kassem RR. Is viscotrabeculotomy superior to conventional trabeculotomy in the management of Egyptian infants with congenital glaucoma? Acta Ophthalmol. 2015;93:e366–71.CrossRef
19.
Zurück zum Zitat William A, Spitzer MS, Doycheva D, Dimopoulos S, Leitritz MA, Voykov B. Comparison of ab externo trabeculotomy in primary open-angle glaucoma and uveitic glaucoma: long-term outcomes. Clin Ophthalmol (Auckland, NZ). 2016;10:929–34. William A, Spitzer MS, Doycheva D, Dimopoulos S, Leitritz MA, Voykov B. Comparison of ab externo trabeculotomy in primary open-angle glaucoma and uveitic glaucoma: long-term outcomes. Clin Ophthalmol (Auckland, NZ). 2016;10:929–34.
20.
Zurück zum Zitat De Moraes CG, Mansouri K, Liebmann JM, Ritch R. Triggerfish Consortium. Association Between 24-Hour Intraocular Pressure Monitored With Contact Lens Sensor and Visual Field Progression in Older Adults With Glaucoma. JAMA Ophthalmol. 2018;136:779–85.CrossRef De Moraes CG, Mansouri K, Liebmann JM, Ritch R. Triggerfish Consortium. Association Between 24-Hour Intraocular Pressure Monitored With Contact Lens Sensor and Visual Field Progression in Older Adults With Glaucoma. JAMA Ophthalmol. 2018;136:779–85.CrossRef
21.
Zurück zum Zitat Salcedo H, Arciniega D, Mayorga M, Wu L. Role of the water-drinking test in medically treated primary open angle glaucoma patients. J Fr Ophtalmol. 2018;41:421–4.CrossRef Salcedo H, Arciniega D, Mayorga M, Wu L. Role of the water-drinking test in medically treated primary open angle glaucoma patients. J Fr Ophtalmol. 2018;41:421–4.CrossRef
22.
Zurück zum Zitat Newman-Casey PA, Robin AL, Blachley T, Farris K, Heisler M, Resnicow K, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122:1308–16.CrossRef Newman-Casey PA, Robin AL, Blachley T, Farris K, Heisler M, Resnicow K, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122:1308–16.CrossRef
23.
Zurück zum Zitat Frech S, Kreft D, Guthoff RF, Doblhammer G. Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients—an observational cohort study (Bhattacharya S, ed). PLoS ONE. 2018;13:e0191185.CrossRef Frech S, Kreft D, Guthoff RF, Doblhammer G. Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients—an observational cohort study (Bhattacharya S, ed). PLoS ONE. 2018;13:e0191185.CrossRef
24.
Zurück zum Zitat Sihota R, Angmo D, Ramaswamy D, Dada T. Simplifying, “target” intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma. Indian J Ophthalmol. 2018;66:495–505.CrossRef Sihota R, Angmo D, Ramaswamy D, Dada T. Simplifying, “target” intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma. Indian J Ophthalmol. 2018;66:495–505.CrossRef
25.
Zurück zum Zitat Kazemian P, Lavieri MS, Van Oyen MP, Andrews C, Stein JD. Personalized prediction of glaucoma progression under different target intraocular pressure levels using filtered forecasting methods. Ophthalmology. 2018;1254:569–77.CrossRef Kazemian P, Lavieri MS, Van Oyen MP, Andrews C, Stein JD. Personalized prediction of glaucoma progression under different target intraocular pressure levels using filtered forecasting methods. Ophthalmology. 2018;1254:569–77.CrossRef
26.
Zurück zum Zitat Hoang TKH, Kim YK, Jeoung JW, Park KH. Relationship between age and surgical success after trabeculectomy with adjunctive mitomycin C. Eye. 2018;32:1321–8.CrossRef Hoang TKH, Kim YK, Jeoung JW, Park KH. Relationship between age and surgical success after trabeculectomy with adjunctive mitomycin C. Eye. 2018;32:1321–8.CrossRef
27.
Zurück zum Zitat Jiang L, Eaves S, Dhillon N, Ranjit P. Postoperative outcomes following trabeculectomy and nonpenetrating surgical procedures: a 5-year longitudinal study. Clin Ophthalmol (Auckland, NZ). 2018;12:995–1002.CrossRef Jiang L, Eaves S, Dhillon N, Ranjit P. Postoperative outcomes following trabeculectomy and nonpenetrating surgical procedures: a 5-year longitudinal study. Clin Ophthalmol (Auckland, NZ). 2018;12:995–1002.CrossRef
28.
Zurück zum Zitat Gilmour DF, Manners TD, Devonport H, Varga Z, Solebo AL, Miles J. Viscocanalostomy versus trabeculectomy for primary open angle glaucoma: 4-year prospective randomized clinical trial. Eye (Lond). 2009;23:1802–7.CrossRef Gilmour DF, Manners TD, Devonport H, Varga Z, Solebo AL, Miles J. Viscocanalostomy versus trabeculectomy for primary open angle glaucoma: 4-year prospective randomized clinical trial. Eye (Lond). 2009;23:1802–7.CrossRef
29.
Zurück zum Zitat Kumaran A, Husain R, Htoon HM, Aung T. Longitudinal changes in bleb height, vascularity, and conjunctival microcysts after trabeculectomy. J Glaucoma. 2018;27:578–84.CrossRef Kumaran A, Husain R, Htoon HM, Aung T. Longitudinal changes in bleb height, vascularity, and conjunctival microcysts after trabeculectomy. J Glaucoma. 2018;27:578–84.CrossRef
30.
Zurück zum Zitat Güven Yılmaz S, Değirmenci C, Palamar M, Yağcı A. Evaluation of filtering bleb function after trabeculectomy with mitomycin C using biomicroscopy, anterior segment optical coherence tomography and in vivo confocal microscopy. Turk J Ophthalmol. 2015;45:132–7.CrossRef Güven Yılmaz S, Değirmenci C, Palamar M, Yağcı A. Evaluation of filtering bleb function after trabeculectomy with mitomycin C using biomicroscopy, anterior segment optical coherence tomography and in vivo confocal microscopy. Turk J Ophthalmol. 2015;45:132–7.CrossRef
31.
Zurück zum Zitat Daher F, Almeida I, Ushida M, Soares B, Dorairaj S, Kanadani FN, et al. Intraocular pressure spikes within first postoperative hours following standard trabeculectomy: incidence and associated factors. Ophthalmic Res. 2018;59:142–7.CrossRef Daher F, Almeida I, Ushida M, Soares B, Dorairaj S, Kanadani FN, et al. Intraocular pressure spikes within first postoperative hours following standard trabeculectomy: incidence and associated factors. Ophthalmic Res. 2018;59:142–7.CrossRef
Metadaten
Titel
Viscotrabeculotomy versus trabeculectomy in the surgical treatment of open angle glaucoma: a single center, randomised controlled trial
verfasst von
Ahmed S. Elwehidy
Tharwat H. Mokbel
Nader H. L. Bayoumi
Amani E. Badawi
Sherein M. Hagras
Publikationsdatum
07.01.2021
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 3/2021
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-020-00801-9

Neu im Fachgebiet Augenheilkunde

Kompetente Gesprächsführung

Mit schwierigen Gesprächen und der Übermittlung schlechter Nachrichten ist der Augenarzt/die Augenärztin im Krankenhaus und in der Praxis immer wieder konfrontiert. Eine gute Arzt-Patienten-Kommunikation basiert auf Respekt und Empathie und …

Sekundäre chorioidale Neovaskularisation – Wirklich so häufig?

Das Auftreten einer sekundären chorioidalen Neovaskularisation ist eine Komplikation im Rahmen einer chronischen Chorioretinopathia centralis serosa. Die Diagnose wird mittels multimodaler Bildgebung gestellt. Die Therapie erfolgt in der Regel mit …

Therapie der Chorioretinopathia centralis serosa im Vergleich – Mikrosekundenpulslaser versus photodynamische Therapie

Zum gegenwärtigen Zeitpunkt steht für die Behandlung der Chorioretinopathia centralis serosa (CCS) keine zugelassene Therapie zur Verfügung. Obwohl die CCS eine hohe Selbstresorptionsrate aufweist, können häufige Rezidive oder eine Chronifizierung …

Diagnostik und Klassifikation der Chorioretinopathia centralis serosa – Was brauche ich wirklich?

Die multimodale Bildgebung spielt bei der Diagnostik und Klassifikation der Chorioretinopathia centralis serosa (CCS) eine bedeutende Rolle. In diesem Beitrag sollen die wichtigsten Bildgebungsmodalitäten bei der CCS wie optische …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.